Global sourcing & supply
Requirement-to-source execution across qualified manufacturers, stockholders and regulated supply channels.
View capability
UK-based healthcare partnerships
ORBIWAY connects qualified manufacturers, institutional buyers and market partners through compliant sourcing, market access and disciplined execution across MENA, Africa, Europe and the UK.
An execution platform for healthcare trade
Every engagement begins with a defined requirement, decision criteria and documentary threshold. That structure allows ORBIWAY to reduce noise, focus the right counterparties and move viable opportunities forward with precision.
Explore our operating modelRequirement-to-source execution across qualified manufacturers, stockholders and regulated supply channels.
View capabilityStructured routes for manufacturers entering priority markets through regulatory, commercial and local-partner alignment.
View capabilityEnd-to-end coordination from opportunity screening and manufacturer engagement through bid readiness and post-award mobilisation.
View capabilityRapid, controlled sourcing for time-critical requirements while preserving origin, batch and documentary visibility.
View capabilitySector intelligence
A broad supply mandate, governed by category-specific qualification and regulatory expectations.
Finished dosage forms, hospital injectables, specialty medicines and selected APIs across regulated supply channels.
Biological products, biosimilar opportunities and temperature-sensitive programmes requiring enhanced coordination.
Clinical equipment and procedure-specific devices sourced against technical, regulatory and service requirements.
High-volume and specialist disposable products for hospitals, procurement groups and public-sector programmes.
Analyzers, reagents, rapid tests and laboratory consumables with attention to compatibility and handling conditions.
Enteral, specialist and condition-specific nutrition for institutional and high-acuity care requirements.
Who we serve
ORBIWAY adapts the engagement architecture to the commercial, regulatory and operational reality of each stakeholder.
Market-entry structuring, distributor alignment, registration coordination and commercially disciplined representation.
Qualified sourcing, portfolio gap coverage, shortage response and documentation-led supplier onboarding.
Requirement-led access to medicines, devices, diagnostics and clinical consumables with clear delivery governance.
Bid intelligence, compliant offer preparation, manufacturer coordination and execution support across public procurement.
Portfolio sourcing, continuity planning and access to high-priority or constrained healthcare categories.
Transparent procurement support for programmes requiring traceability, urgency and cross-border coordination.
International healthcare corridors
ORBIWAY prioritises corridors where supply quality, regulatory feasibility, buyer demand and local execution can be aligned into a bankable pathway.
Explore market prioritiesQuality & compliance
Qualification is proportionate to product risk, destination market and transaction structure. Named standards are verified engagement by engagement—not assumed.
Executive insights
Practical perspectives on supply, market access, public procurement and regulated growth.
Market access
A disciplined expansion programme aligns regulatory feasibility, pricing logic and local execution before launch commitments are made.
Discuss the implicationTender strategy
The strongest bids are assembled before the deadline window narrows, with documentary risk and freight assumptions already controlled.
Discuss the implicationShortage intelligence
Urgency should accelerate governance, not remove it. Origin, authority, batch position and route-to-market remain decisive.
Discuss the implicationStart a focused conversation
Share the product, market, timeline and required evidence. ORBIWAY will assess fit, define the next decision point and route the inquiry to the appropriate business pathway.